The Latest Cardiac and Vascular News
Core Sound Imaging and Us2.ai finalize integration agreement. Us2.ai joins Studycast Integration Program, bringing AI-automated Echocardiography analysis and decision support tools into clients’ imaging and reporting solution. Us2.ai is an FDA cleared app that reports on heart structure and function, with fully automated analyses of ALL heart chambers using both 2D and […]
Company Believes the Continuous Accumulation of Peer-Reviewed Data will Accelerate the Adoption of its Novel Interventional Endovascular System Once Commercialized HINGHAM, Mass., June 16, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) is encouraged by the continued participation and level of enthusiasm being demonstrated by the Key Opinion Leaders […]
Ghent, Belgium – 16 June 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical”), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that its alfapump has won the ‘Best Technology’ Award at the European Mediscience Awards in […]
ST. LOUIS, June 15, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it intends to initiate a first-in-human trial to support the CE Mark submission for its MAGiC™ catheter. Stereotaxis’ MAGiC catheter is a robotically-navigated […]
Cardiovascular risk reduction with bempedoic acid shown via the Cholesterol Treatment Trialists’ (CTT) Major Vascular Event endpoint is comparable to the normalized risk reduction with statins observed in the CTT meta-analyses ANN ARBOR, Mich., June 15, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today presented results from an analysis comparing […]
CAMZYOS is the first and only FDA-approved cardiac myosin inhibitor that specifically targets the underlying source of obstructive HCM VALOR-HCM is the second Phase 3 trial in which CAMZYOS demonstrated significant improvement in symptoms of obstructive HCM June 15, 2023 08:23 PM Eastern Daylight Time PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced […]
The DETOUR 2 study is a prospective, single-arm, international, multi-center clinical evaluation of the novel DETOURTM System for fully percutaneous femoropopliteal bypass procedures. IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive therapies for the interventional treatment of vascular disease, today announced the 24-month results […]
WEST CHESTER, Pa., June 15, 2023 /PRNewswire/ — VESTECK (WWW.VESTECK.com) is a clinical stage medical device company focused on bringing a proprietary technology to the aortic repair and structural heart markets. The “SUTURE-TIGHT™” catheter comes preloaded with 4 pair of nitinol sutures, it secures endovascular (EVAR/TEVAR) grafts to the aorta on initial implant […]
Core Sound Imaging and Echo IQ finalize integration agreement for EchoSolv™ and the Studycast® system, through the Studycast Integration Program. This partnership enables Studycast clients to seamlessly integrate AI-powered detection of Aortic Stenosis into their imaging and reporting workflow. RALEIGH, N.C., June 14, 2023 /PRNewswire/ — Core Sound Imaging, Inc., creators of […]
Verve to Receive $60 Million in Combined Upfront Payment and Equity Investment; Additional Capital Positioned to Extend Verve’s Expected Cash Runway into 2026 Verve has Opt-in Rights to Co-fund and Share in Potential Margins of Products Resulting from the Collaboration BOSTON, June 15, 2023 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc. […]
